Ganoderma triterpene and pharmaceutical composition and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 峨眉山国芝堂生物科技有限公司
- Publication Date
- 2017-08-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to triterpenoids, in particular to triterpenoids extracted from fungi and their use as aldose reductase inhibitors. Background technique
[0002] Ganoderma lucidum (Leyss.ex Fr.) Karst. belongs to Eumycota, Basidiomycotina, Hymenomycetes, Aphyllophorales, Gamodermataceae , Ganoderma (Ganoderma) class. It is recorded in "Chinese Materia Medica" that "it is sweet in nature; flat in taste; non-toxic; it belongs to the lung, heart, spleen, and kidney meridians. It benefits qi and blood; calms the mind; strengthens the spleen and stomach. It is mainly used to treat fatigue, palpitations, insomnia, dizziness, and fatigue. , chronic cough, asthma, coronary heart disease, silicosis, and tumors." "Chinese Pharmacopoeia" lists Ganoderma lucidum as a traditional Chinese medicinal material, in which Ganoderma lucidum polysaccharides, triterpenes, nucleosides, alkaloids, amino acid polypeptides, trace elements and other ingredients ar...